| PERIOD ENDING | 3-Apr-09 | 28-Mar-08 | 30-Mar-07 | | Total Revenue | 16,739,900 | 16,499,500 | 14,854,900 | | Cost of Revenue | 13,260,700 | 13,151,900 | 11,813,500 | | | Gross Profit | 3,479,200 | 3,347,600 | 3,041,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,082,800 | 975,400 | 918,300 | | Non Recurring | 18,900 | 155,800 | 316,100 | | Others | 1,185,500 | 1,198,600 | 1,073,600 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,192,000 | 1,017,800 | 733,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,600 | 85,500 | 90,800 | | Earnings Before Interest And Taxes | 1,209,600 | 1,103,300 | 824,200 | | Interest Expense | 260,500 | 185,400 | 217,900 | | Income Before Tax | 949,100 | 917,900 | 606,300 | | Income Tax Expense | (166,100) | 373,300 | 209,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,115,200 | 544,600 | 397,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,115,200 | 544,600 | 397,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,115,200 | $544,600 | $397,300 |
|
1.48% Nasdaq 
Income Statement
